-
Increasing HIV In Women Is A Key Driver For The Cervical Cancer Drugs Market
13 Oct 2021 09:08 GMT
… tablets. These drugs ease the localized treatment of cervical … Pharmaceuticals for Human Use (ICH)'s Clinical Trials … Registry, 851B Gel is in trial phase … By Product (Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient …
-
Biotech CEO Pioneers A Paradigm-Shifting Drug Development Model
21 Sep 2021 12:02 GMT
… to developing life-saving treatments. Theuer’s alternative … trials and FDA approvals.
“A more streamlined approach to drug … notable biotechnology firms including TargeGen, Inc. and IDEC Pharmaceutical Corp. … program at Harbor-UCLA Medical Center and was …
-
Exelixis' Cabometyx Combo Trial Shows Benefit In Kidney Cancer Regardless Of Prior Surgery
16 Sep 2021 12:12 GMT
… the 2021 European Society for Medical Oncology Congress (ESMO21).
The Phase … Inc's (NYSE: PFE) Sutent (sunitinib).
At a median follow … of the European Society for Medical Oncology Congress (ESMO21)
© 2021 Benzinga …
-
Global Lung Cancer Drugs Market Trends, Strategies, And Opportunities In The Lung Cancer Drugs Market 2021-2030
13 Sep 2021 10:54 GMT
… , drug manufacturers are developing targeted drug therapies for better diagnosis and treatment of … (UCC)), By Product (Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient (Pazopanib …
-
Global Urology Medical Lasers Market Trends, Strategies And Opportunities In The Urology Medical Lasers Market 2021-2030
02 Sep 2021 10:58 GMT
… . Urology medical lasers are used in the treatment of medical conditions related … Urology Medical Lasers Global Market Report 2021:
Kidney Cancer Drugs Global … UCC)), By Product (Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient ( …
-
Global Kidney Cancer Drugs Market Trends, Strategies, And Opportunities In The Kidney Cancer Drugs Market 2021-2030
06 Aug 2021 06:07 GMT
… therapy. Under this treatment, the drugs from vascular endothelial growth … food and drug administration (FDA) approval to combine their drug Pembrolizumab, … UCC)
By Product: Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient …
-
Urological Cancer Drugs Market Growth 2021 : Movements by Key Findings, Definition, SWOT Analysis, Applications, Trends and Forecast to 2026 with Leading Regions and Countries Data
07 Jul 2021 09:44 GMT
… GlaxoSmithKline
● Indevus Pharmaceuticals Inc
Urological Cancer Drugs Market Analysis and … (Axitinib)
● Votrient (Pazopanib Hydrochloride)
● Sutent (Sunitinib Malate)
● Zytiga (Abiraterone Acetate … Click Here :Gaucher Disease Treatment Market Growth 2021 : …
-
Deciphera Pharmaceuticals, Inc. (DCPH) Q1 2021 Earnings Call Transcript
05 May 2021 11:39 GMT
… and welcome to Deciphera Pharmaceuticals First Quarter 2021 Financial … developing and commercializing new medicines for patients with cancer. … drug as monotherapy into an earlier line of treatment … ve been getting from doctors especially around safety and …
-
Top Drugs Losing Patent Exclusivity in 2021
29 Apr 2021 06:57 GMT
… acid), Amarin's drug for hypertriglyceridemia and cardiovascular disease … ANDA litigation action against Hikma Pharmaceuticals (see "Amarin Pharma, … tentative FDA approval.
Sutent (sunitinib), is marketed by Pfizer for the treatment of …
-
Renal Cell Cacinoma Drugs Market Report Size 2021 Growth, Share, Product Types and Application, Top Key Players with Sales, Price, Business Overview, SWOT Analysis 2026
23 Apr 2021 05:11 GMT
… Squibb ● Genentech ● Immatics Biotechnologies ● AVEO Oncology ● Eisai ● Acceleron ● Rexahn Pharmaceuticals ● Bionomics ● Cerulean … Cacinoma Drugs market from 2016 to 2026 is primarily split into: ● Sutent …
About
© 1995-2021